Abstract
The present thesis focuses on the development, synthesis, and systematic investigation of novel biodegradable, pH-responsive zwitterionic nanocarriers for the targeted and controlled delivery of paclitaxel (PTX), a widely used chemotherapeutic agent for various cancer types. These nanocarriers are based on copolymers of poly(lactic acid) (PLA) and poly(ethylene adipate) (PEAd), functionalized with grafted sulfobetaine methacrylate (SBMA) side chains to achieve combined functionalities, including pH-responsiveness (acidic tumor microenvironment specificity), enhanced hydrophilicity, reduced nonspecific interactions, and controlled biodegradation. In this context, a synthetic strategy for the preparation of PLA/PEAd copolymers was established, and an extensive structural characterization was performed using a combination of spectroscopic (¹H-NMR, FTIR) and crystallographic techniques (XRD), thermal analysis (DSC, TGA), molecular weight determination, contact angle measurements, and biocompatibility assessment. Interestingly, hydrolytic degradation studies demonstrated the significant contribution of the PEAd segments in facilitating water uptake and accelerating degradation under acidic conditions that mimic the tumor microenvironment. Significant attention was given to exploring the relationship between copolymer structure and crystallinity, as well as the impact of these parameters on nanoparticle morphology and physicochemical properties, including particle size, size distribution, and PTX encapsulation efficiency. By varying the sonication time during nanoparticle formation, it was possible to tune particle dimensions and distribution, enabling a preliminary investigation of the relationship between nanoparticle size and PTX release rate, an essential design parameter for systems intended to achieve prolonged circulation and effective tumor penetration. Furthermore, the presence of SBMA groups contributed to the pH-mediated modulation of PTX release through dynamic rearrangement of the nanoparticle surface chemistry, while in vitro biocompatibility studies confirmed reduced cytotoxicity toward healthy cells and enhanced anticancer activity, demonstrating the suitability of the system as a targeted delivery platform. Thermal analysis combined with X-ray diffraction provided insights into the physical state of PTX within the nanostructures, revealing predominantly amorphous encapsulation and stable molecular dispersion within the polymer matrix. Long-term stability studies (0, 6, and 12 months) indicated a gradual reduction in crystallinity and changes in the endothermic melting transitions of PTX, attributed to mild chain rearrangements in the PLA/PEAd matrix and progressive redistribution of PTX within the softened polymeric domains. The findings demonstrate that the newly synthesized PLA/PEAd-SBMA copolymers possess several critical characteristics for the development of pH-responsive nanocarriers capable of targeted cytotoxic drug delivery, with improved stability, reduced nonspecific biomolecular interactions, and tunable degradation and release profiles, highlighting the potential of the proposed systems as versatile platforms for advanced nanomedicine applications.